Athira Pharma stock soars after acquiring rights to Phase 3 breast cancer drug
Athira Pharma stock soars after acquiring rights to Phase 3 breast cancer drug
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
4279 articles about stock market
Athira Pharma stock soars after acquiring rights to Phase 3 breast cancer drug
NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ: SDA), an innovative leader in AI cloud-based...
Abivax stock rises after announcing acceptance of 22 abstracts at ECCO 2026
You've probably never heard of RRP Semiconductor Ltd., but you're certainly going to wish you had invested in it two years ago
Integer stock rises after activist investor reportedly builds stake and urges sale
Can Micron blowout memory outlook turn around AI sentiment?
Curiously, those events which have shaken markets most severely in recent years are low down the list of priorities for 2026 in investor mindsets.
Birkenstock sees muted sales growth and profit as tariffs hurt margins
Trump Media bets on fusion energy with $6 billion TAE deal
Micron's dramatic beat has analysts feeling upbeat about the company's ability to be a huge beneficiary of the AI boom.
Cognizant (NASDAQ: CTSH) today announced a multi-year strategic partnership with Microsoft to help global enterprises become AI-powered frontier firms: org...
BOSTON, December 18, 2025--Dynatrace, (NYSE: DT), the leading AI-powered observability platform, today announced it has expanded its collaboration with Goo...